Enzolytics Inc (PK) (ENZC) Fundamentals

Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.
Share Info
Market Cap$ 160,202,675
Shares Authorized3,000,000,000
Shares Outstanding2,830,435,953
Shares Outstanding Date08/10/2022
Shareholder Count193
Shareholder Count Date09/30/2020
Float Date03/31/2022
Short Interest6,508,224
Short Interest Date07/29/2022
Reporting Info
Reporting StatusAlternative Reporting Standard
Audit Status-
AuditorMaloneBailey, LLP
Auditor Address10350 Richmond Avenue,
Suite 405
Houston, Texas 77042
Auditor Websitehttp://www.malonebailey.com
IR FirmTen Associates LLC
IR Firm Address11529 N. 120 th Street
Suite 01
Scottsdale, Arizona 85259
IR Firm Websitehttp://www.tensassociatesllc.com
Legal CounselMorgan E. Petitti, Esq.
Legal Counsel Address118 W. Streetsboro Road
Suite #317
Hudson, Ohio 44236
Legal Counsel Website-
Fiscal Year End12/31
ADR Ratio-
Transfer AgentEmpire Stock Transfer Inc.
Transfer Agent Address1859 Whitney Mesa Dr.
Henderson, NV 89014
Depository Websitehttp://www.empirestock.com
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:ENZC
OTC Market TierPink Current
Security TypeCommon Stock
CIK Number0001421851
Address2000 North Central Expressway
Plano, Texas 75074
Fax #-
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesCSO - Harry Zhabilov , Jr.
CSO - Harry Zhabilov , Jr.
CEO - Charles Cotropia
CEO - Charles Cotropia
Chief Scientific Officer - Dr. Joseph Cotropia
Chief Scientific Officer - Dr. Joseph Cotropia
COO - Dr. Gaurav Chandra
COO - Dr. Gaurav Chandra
Number of Employees6
Incorporation StateDelaware
Incorporation CountryUSA
Incorporation Year2007

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.